Diagnosis and Management of Essential Thrombocythemia in Sanjiwani Hospital Gianyar, Bali: A Case Report
Abstract
Abstract. Essential thrombocythemia (ET) is a very rare disorder with 1- /100,000 population in the world. The incidence of this abnormality is still obscure in Indonesia. We report a case of ET, women of age 74 years old that came to Sanjiwani Hospital with gum bleeding. This case is confirmed based on WHO criteria of ET which are the increasing of thrombocyte of a number of increase >450 /µL3, proliferation of megakaryocyte cell on bone marrow biopsy, also not meeting any other WHO criteria for also not meeting any other WHO criteria for BCR-ABL1+CML, Polycythemia Vera, Chronic Myeloid Leukemia, Myelodysplastic Syndrome, or other myeloid neoplasm diseases. Management of this case is based on risk adapted treatment algorithm considering three major risk factors for thrombosis (history of thrombosis, JAK2/MPL mutations, and advanced age). This case is categorized as high risk patient for thrombosis, so that treated with antiplatelet aggregation (aspilets) and anagrelide after hydroxyurea clinically unresponsive.References
LJ Spiyak. Harrison’s Principal of Internal Medicine. 19th Ed. Mc Graw Hill Educ. 2015;676–8.
I Alwi, S. Salim, R Hidayat, J Kurniawan DLT. Penatalaksanaan di Bidang Ilmu Penyakit Dalam Panduan Praktik Klinis. 2015. 551-4 p.
M A Papadakis SJM. Current Medical Diagnosis and Treatment. In: Mc Graw Hill lMedical. 2013. p. 513–5.
Institutet K. Clinical and Epidemiological Studies in Malin Hultcrantz Stockholm 2013. 2013.
Moulard O, Mehta J, Fryzek J, Olivares R, Iqbal U, Mesa RA. Epidemiology of myelofibrosis, essential thrombocythemia, and polycythemia vera in the European Union. Eur J Haematol. 2014;92(4):289–97.
Briére JB. Essential thrombocythemia. Orphanet J Rare Dis. 2007;2(1):1–17.
Mehta J, Wang H, Iqbal SU, Mesa R. Epidemiology of myeloproliferative neoplasms in the United States. Leuk Lymphoma. 2014;55(3):595–600.
Oehadian A. Aspek Hematologi Tuberkulosis. 2003;
Bakta IM. Hematologi Klinik Ringkas. In: Buku Kedokteran EGC. 2011. p. 1472–82.
Hernández-Boluda JC, Gómez M. Target hematologic values in the management of essential thrombocythemia and polycythemia vera. Eur J Haematol. 2015;94(1):4–11.
Arber DA, Orazi A, Hasserjian R, Borowitz MJ, Beau MM Le, Bloomfield CD, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391–406.
Rumi E, Cazzola M. How I treat How I treat essential thrombocythemia. Blood. 2016;128(20):2403–14.
Abstract viewed = 1067 times
PDF downloaded = 500 times
